These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36592066)

  • 1. Metabolomics as a Critical Tool for Studying Clinical Surgery.
    Gao Z; Zhou W; Lv X; Wang X
    Crit Rev Anal Chem; 2024; 54(7):2245-2258. PubMed ID: 36592066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.
    Pedrini M; Cao B; Nani JVS; Cerqueira RO; Mansur RB; Tasic L; Hayashi MAF; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():182-188. PubMed ID: 30904564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements in metabolomics research in benign gallbladder diseases: A review.
    Du Y; Wijaya WA; Liu WH
    Medicine (Baltimore); 2024 May; 103(21):e38126. PubMed ID: 38788004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of metabolomics in personalized medicine for diabetes.
    Chowdhury S; Faheem SM; Nawaz SS; Siddiqui K
    Per Med; 2021 Sep; 18(5):501-508. PubMed ID: 34406076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.
    Lin C; Tian Q; Guo S; Xie D; Cai Y; Wang Z; Chu H; Qiu S; Tang S; Zhang A
    Molecules; 2024 May; 29(10):. PubMed ID: 38792060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
    Di Minno A; Gelzo M; Caterino M; Costanzo M; Ruoppolo M; Castaldo G
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics in rheumatic diseases: desperately seeking biomarkers.
    Guma M; Tiziani S; Firestein GS
    Nat Rev Rheumatol; 2016 May; 12(5):269-81. PubMed ID: 26935283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Applications of Metabolomics in Clinical Pharmacology.
    Pang H; Jia W; Hu Z
    Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review.
    Demicheva E; Dordiuk V; Polanco Espino F; Ushenin K; Aboushanab S; Shevyrin V; Buhler A; Mukhlynina E; Solovyova O; Danilova I; Kovaleva E
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.
    Jaber M; Kahwaji H; Nasr S; Baz R; Kim YK; Fakhoury M
    Adv Exp Med Biol; 2024; 1456():359-378. PubMed ID: 39261438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics: Perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity.
    Bonneau E; Tétreault N; Robitaille R; Boucher A; De Guire V
    Clin Biochem; 2016 Mar; 49(4-5):377-84. PubMed ID: 26794636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical pitfalls and challenges in clinical metabolomics.
    Kohler I; Verhoeven A; Derks RJ; Giera M
    Bioanalysis; 2016 Jul; 8(14):1509-32. PubMed ID: 27323646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications-Review.
    Shahisavandi M; Wang K; Ghanbari M; Ahmadizar F
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Trends and Innovations in Bioanalytical Techniques of Metabolomics.
    Zhang T; Zhang A; Qiu S; Yang S; Wang X
    Crit Rev Anal Chem; 2016 Jul; 46(4):342-51. PubMed ID: 26337255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
    Dona AC; Coffey S; Figtree G
    Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.